Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 1 - Drugs for disorders of the alimentary tract or the digestive system
Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798)
11/2000
11/23/2000CA2374108A1 Anionic polymers as toxin binders and antibacterial agents
11/23/2000CA2374053A1 Secreted polypeptides and corresponding polynucleotides
11/23/2000CA2373935A1 A method of identifying therapeutic compounds for a treatment of hepatic disorders
11/23/2000CA2373824A1 Organ, tissue and cell-specific immuno-therapeutic for chronic viral infections and inflammatory, degenerative and proliferative diseases, in particular of the liver, and for cancer, based on a recombinant parapox virus
11/23/2000CA2373607A1 Cyclic amine derivatives and their uses
11/23/2000CA2373532A1 Morpholino-n-ethyl ester derivative of an indole spla2 inhibitor
11/23/2000CA2373231A1 Extracellular signaling molecules
11/23/2000CA2373191A1 Full-length molecules expressed in human tissues
11/23/2000CA2372934A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
11/23/2000CA2372926A1 143 human secreted proteins
11/23/2000CA2372494A1 Compounds having cytokine inhibitory activity
11/23/2000CA2372426A1 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/23/2000CA2372102A1 Lawsonia derived gene and related omph polypeptides, peptides and proteins and their uses
11/23/2000CA2372098A1 Lawsonia derived gene and related flge polypeptides, peptides and proteins and their uses
11/23/2000CA2372095A1 Lawsonia derived gene and related sodc polypeptides, peptides and proteins and their uses
11/23/2000CA2372044A1 Imidazo- and pyrrolo[1,2-a]pyrimid-4-ones as gonadotropin-releasing hormone receptor antagonists
11/23/2000CA2370245A1 Enzyme-activated anti-tumor prodrug compounds
11/23/2000CA2370066A1 Thiazolopyrimidines useful as tnf.alpha. inhibitors
11/23/2000CA2368640A1 A composition containing carvacrol and thymol for use as a bactericide
11/23/2000CA2368620A1 Genetic modification of male germ cells for generation of transgenic species and genetic therapies
11/23/2000CA2368593A1 Anti-inflammatory therapy for inflammatory mediated infection
11/22/2000EP1054017A1 Salts of thrombin inhibitors
11/22/2000EP1053989A2 Hydroxydiphenyl ether compounds
11/22/2000EP1053743A1 Composition for the treatment of halitosis
11/22/2000EP1053323A2 Human receptor proteins
11/22/2000EP1053249A2 Peptide inhibitors of the serine protease activity associated to the ns3 protein of hcv, relevant uses and process of production
11/22/2000EP1053233A1 Hydroxamic and carboxylic acid derivatives
11/22/2000EP1053230A1 Triazine antiviral compounds
11/22/2000EP1053014A1 BIOLOGICALLY ACTIVE HEMAGGLUTININ FROM TYPE A $i(CLOSTRIDIUM BOTULINUM) AND METHODS OF USE
11/22/2000EP1053001A1 Novel mixed amylin activity compounds
11/22/2000EP1052986A1 Anti-inflammatory agents
11/22/2000EP1052977A1 Treatment of chronic inflammatory disorders of the gastrointestinal tract
11/22/2000EP1052967A2 Antiplaque oral composition and method
11/22/2000EP0669936B1 Mercaptoacetylamide bicyclic lactam derivatives useful as inhibitors of enkephalinase and ace
11/22/2000CN1274387A HCVE mimotopes of hypervariable region 1 and uses
11/22/2000CN1274354A Robustaflavone, intermediates and analogues and method for prepn. method
11/22/2000CN1274344A Novel vitamin D analogues
11/22/2000CN1274288A Peptide-containing & alpha; -ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274284A Methods of modulating serine/threnoine protein kinase function with 5-azaquinoxaline-based compounds
11/22/2000CN1274283A Quinoline-containing & Alpha;-ketoamide cysteine and serine protease inhibitors
11/22/2000CN1274280A Delayed total release gastrointestinal drug delivery system
11/22/2000CN1274279A Film-coated tablet for improved upper gastrointestinal tract safety
11/22/2000CN1273853A Powdered Chinese medicine for treating diarrhea
11/22/2000CN1273845A 胃炎胶囊 Gastritis Capsules
11/22/2000CN1273843A Gastrointestinal health-care product and its preparing process
11/22/2000CN1273842A Multi-nutrient instant particles for refreshing brain, loosing weight, making bone stronger, blackening hair and elongating life
11/22/2000CN1273832A Compound Yexiazhu medicine and preparing process thereof
11/22/2000CN1273831A Medicie for treating gastritis and pathologic affection before gastromucosa cancer
11/22/2000CN1058710C Benzamide derivatives, process for prepn. thereof and pharmaceutical compsn. comprising same
11/22/2000CN1058625C Instant powder for treating hepatitis B
11/22/2000CN1058623C Anti-hepatitis B capsule
11/22/2000CN1058622C Rehabilitation powder for hepatitis B
11/22/2000CN1058611C Antidiarrheal Chinese medicine
11/21/2000US6150557 Compounds
11/21/2000US6150417 Administering to warm blooded animals compounds such as n-tert-butyl-5-((2-(2-methoxyphenoxy)ethyl)amino)pentanamide for inducing antiemetic activity; treating anxiety, depression, and sleep disorders
11/21/2000US6150380 Crystalline form of omeprazole
11/21/2000US6150378 Peptidyl-containing α-ketoamide cysteine and serine protease inhibitors
11/21/2000US6150376 Bi- and tri-cyclic aza compounds and their uses
11/21/2000US6150370 1,3-dinitrocyclic compound treats numerous diseases caused by undesired metalloprotease activity, such as tumor metastasis, osteoarthritis, rheumatoid arthritis, skin inflammation, ulcerations, and periodontitis
11/21/2000US6150340 RNA-dependent amidotransferase from Staphylococcus aureus
11/21/2000US6150325 Bicyclic tachykinins antagonists, preparation thereof and their use in pharmaceutical compositions
11/21/2000US6150139 Preparing bactericide; culturing cells, separating the supernatant, separate bateriocin from supernatant, recover bacteriocin
11/21/2000US6150134 Recombinant microorganism polypeptide; for the diagnosis, treatment and prevention of preferential microorganismal infections; for the purification of recombinant polypeptides
11/21/2000US6149908 Use of lactoperoxidase, a peroxide donor and thiocyanate for the manufacture of a medicament for treating Helicobacter pylori infection
11/21/2000CA2038578C Delivery of agents
11/21/2000CA2020477C Sustained release formulations of water soluble peptides
11/16/2000WO2000068380A2 Extracellular matrix and adhesion-associated proteins
11/16/2000WO2000068246A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy
11/16/2000WO2000068224A1 Substituted benzolactam compounds
11/16/2000WO2000068215A1 Diphenyl-1,2,3-thiadiazol-3-oxides, compositions and methods of use
11/16/2000WO2000068213A1 Substituted bicyclic compounds
11/16/2000WO2000068209A2 1,5-benzodiazepine derivatives as cck-a receptor agonists
11/16/2000WO2000068198A2 Heterosubstituted pyridine derivatives as pde 4 inhibitors
11/16/2000WO2000068188A1 Propanoic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067917A1 Permeabilizing biofilms
11/16/2000WO2000067847A2 Use of dopamine d3 receptor ligands for producing medicaments for treating kidney disorders
11/16/2000WO2000067799A1 Compositions for treatment of disorders of the oesophagus
11/16/2000WO2000067796A1 Treatment of autoimmune diseases with antagonists which bind to b cell surface markers
11/16/2000WO2000067791A1 Ccr4 antagonists in sepsis
11/16/2000WO2000067761A1 Compositions and methods for identifying antigens which elicit an immune response
11/16/2000WO2000067747A1 Docusate hard gelatin capsules
11/16/2000WO2000067746A1 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors
11/16/2000WO2000067734A2 Use of phthalazine derivatives
11/16/2000WO2000067589A1 Method for manufacturing rumen bypass feed supplement
11/16/2000WO2000054728A3 Use of a bacterial composition for treating periodontal diseases
11/16/2000WO2000042168A3 Bifidobacterium in the treatment of inflammatory disease
11/16/2000WO2000039285A3 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof
11/16/2000WO2000038665A3 Use of an integrin antagonist and one or more antineoplastic agents as a combination therapy in the treatment of neoplasia
11/16/2000WO2000038536A3 Inhibitors of the bitter taste response
11/16/2000WO2000037639A3 Lymphocytic membrane proteins
11/16/2000WO2000034468A3 Muc-1 antagonists and methods of treating immune disorders
11/16/2000WO2000034331A3 Analogues of glp-1
11/16/2000WO2000034285A3 Substituted benzofuranoindoles and indenoindoles as novel potassium channel openers
11/16/2000WO2000027377A3 Phosphinate peptide analogs for the treatment of fibrotic disorders
11/16/2000WO2000026224A3 Novel macrolide antibiotics
11/16/2000WO2000024907A3 Library of novel "unnatural" natural products
11/16/2000WO2000018365A3 Fast dissolving orally consumable films
11/16/2000DE19922407A1 Preparing medicament for treating viral infections, liver diseases or cancer, comprising recombinant parapoxvirus targeted towards specific organs, cells or tissues
11/16/2000DE19921567A1 Verwendung von Phthalazine-Derivaten Use of derivatives phthalazines
11/16/2000DE19920247A1 Arzneimittel mit einem Gehalt an Verbindungen mit einem Stickstoff-Sauerstoff-Heterocyclus als Wirkstoff und ihre Verwendung Medicaments with an amount of compounds having a nitrogen-oxygen heterocycle as active ingredient and their use
1 ... 1061 1062 1063 1064 1065 1066 1067 1068 1069 1070 1071 1072 1073 1074 1075 1076 1077 1078 1079 1080 1081 ... 1258